Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Biosimilars Deals 2024
Chris Vindurampulle
Diversity
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
Paul Johns
PipCast®
PTE
Trade Marks
Webinars

Biocon and Biomm Enter Agreement To Supply Generic Ozempic® (semaglutide) in Brazil

Apr 17, 2024

On 17 April 2024, Biocon announced that it signed an exclusive licensing and supply agreement for generic Ozempic® (semaglutide) in Brazil.  Biocon will develop, manufacture and supply the semaglutide product and Biomm is responsible for regulatory and commercialisation strategies in Brazil.

This follows news earlier this month that Hangzhou Jiuyan Gene Engineering’s application for a generic version of Ozempic® (semaglutide) was accepted by regulators in China.